Biofortuna | GenomeWeb


The new investment will support an expanding contract business as well as in-house MDx development.

NEW YORK (GenomeWeb) — Citing increased demand from companies outsourcing freeze-drying of diagnostic kits, molecular diagnostics firm Biofortuna has expanded its PCR reagent lyophilization production service.

NEW YORK (GenomeWeb News) — Biofortuna said today that it has received 510(k) clearance from the US Food and Drug Administration for its SSPGo HLA PCR kits.

NEW YORK (GenomeWeb News) – Trilink BioTechnologies said today that it has inked a new licensing agreement with Biofortuna allowing the UK firm to use Trilink's hot start deoxynucleotides for freeze-drying molecular diagnostic kit development and production service.

NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Biofortuna today announced a £1.3 million investment ($2.0 million), which will go toward the expansion of its custom service and manufacturing business.

NEW YORK (GenomeWeb News) – Becton Dickinson said this week it has declared a quarterly dividend of $45 per share, payable on Sept. 28 to shareholders of record on Sept. 7. The indicated annual dividend rate is $1.80 per share.

NEW YORK (GenomeWeb News) – Liverpool, UK-based Biofortuna announced today that it has extended an exclusive distribution agreement with Abbott.

Biofortuna will design, develop, and manufacture a range of freeze-dried HLA-typing kits with the brand name SSPGo for Abbott's molecular diagnostics business.

Upon regulatory approvals, Abbott will have exclusive distribution rights in the US and all other geographies, excluding France, Spain, Portugal, and the Benelux countries.


In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.